Switch to
More onapp

Dr Reddy's Laboratories Ltd

DRREDDY
Health CarePharmaceuticals
LargecapWith a market cap of ₹73,001 cr, stock is ranked 73
Low RiskStock is 1.33x as volatile as Nifty
4,397.5516.40 (-0.37%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹73,001 cr, stock is ranked 73
Low RiskStock is 1.33x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
33.45
PB RatioPB Ratio
3.80
Dividend YieldDiv. Yield
0.68%
Sector PESector PE
35.81
Sector PBSector PB
4.37
Sector Div YldSctr Div Yld
0.90%

Forecast & RatingsDetailed Forecast 

85%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Brands

Dr.Reddy's

Pharmaceutical company

Investor PresentationView older 

Jun 21, 2022

PDF
View Older Presentations

Brands

Dr.Reddy's

Pharmaceutical company

Financial TrendFinancial statements 

201920202021202215.8318.1919.3922.101.952.031.952.18
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

ESOP/ESPS/SBEB Scheme 
Announced OnSep 30, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange about ESOP/ESPS/SBEB Scheme | Download

Dr. Reddy's Laboratories Limited has informed the Exchange about ESOP/ESPS/SBEB Scheme | Download

Closure of trading window 
Announced OnSep 28, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange that the trading window for dealing in securities of the Company will be closed from Friday, September 30, 2022, to Sunday, October 30, 2022 (both days inclusive). | Download

Dr. Reddy's Laboratories Limited has informed the Exchange that the trading window for dealing in securities of the Company will be closed from Friday, September 30, 2022, to Sunday, October 30, 2022 (both days inclusive). | Download

Cash Dividend 
Ex. DateJul 11, 2022

Final • Div/Share: ₹ 30

See all events